1127 related articles for article (PubMed ID: 24824341)
1. Hippocampal NR2B-containing NMDA receptors enhance long-term potentiation in rats with chronic visceral pain.
Chen Y; Chen AQ; Luo XQ; Guo LX; Tang Y; Bao CJ; Lin L; Lin C
Brain Res; 2014 Jun; 1570():43-53. PubMed ID: 24824341
[TBL] [Abstract][Full Text] [Related]
2. Tyrosine phosphorylation of the NR2B subunit of the NMDA receptor in the spinal cord contributes to chronic visceral pain in rats.
Luo XQ; Cai QY; Chen Y; Guo LX; Chen AQ; Wu ZQ; Lin C
Brain Res; 2014 Jan; 1542():167-75. PubMed ID: 24125810
[TBL] [Abstract][Full Text] [Related]
3. Late phase of long-term potentiation induced by co-application of N-methyl-d-aspartic acid and the antagonist of NR2B-containing N-methyl-d-aspartic acid receptors in rat hippocampus.
Oh-Nishi A; Saji M; Satoh SZ; Ogata M; Suzuki N
Neuroscience; 2009 Mar; 159(1):127-35. PubMed ID: 19010396
[TBL] [Abstract][Full Text] [Related]
4. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus.
Zhong WX; Dong ZF; Tian M; Cao J; Xu L; Luo JH
Neuroscience; 2006 Sep; 141(3):1399-413. PubMed ID: 16766131
[TBL] [Abstract][Full Text] [Related]
5. Enhanced NMDA receptor-dependent LTP in the epileptic CA1 area via upregulation of NR2B.
Müller L; Tokay T; Porath K; Köhling R; Kirschstein T
Neurobiol Dis; 2013 Jun; 54():183-93. PubMed ID: 23313317
[TBL] [Abstract][Full Text] [Related]
6. Involvement of N-methyl-D-aspartate receptor subunits in zinc-mediated modification of CA1 long-term potentiation in the developing hippocampus.
Takeda A; Itagaki K; Ando M; Oku N
J Neurosci Res; 2012 Mar; 90(3):551-8. PubMed ID: 22057830
[TBL] [Abstract][Full Text] [Related]
7. Role of the spinal cord NR2B-containing NMDA receptors in the development of neuropathic pain.
Qu XX; Cai J; Li MJ; Chi YN; Liao FF; Liu FY; Wan Y; Han JS; Xing GG
Exp Neurol; 2009 Feb; 215(2):298-307. PubMed ID: 19046970
[TBL] [Abstract][Full Text] [Related]
8. Dehydroepiandrosterone sulfate prevents ischemia-induced impairment of long-term potentiation in rat hippocampal CA1 by up-regulating tyrosine phosphorylation of NMDA receptor.
Li Z; Zhou R; Cui S; Xie G; Cai W; Sokabe M; Chen L
Neuropharmacology; 2006 Oct; 51(5):958-66. PubMed ID: 16895729
[TBL] [Abstract][Full Text] [Related]
9. Selective subunit antagonists suggest an inhibitory relationship between NR2B and NR2A-subunit containing N-methyl-D: -aspartate receptors in hippocampal slices.
Mallon AP; Auberson YP; Stone TW
Exp Brain Res; 2005 Apr; 162(3):374-83. PubMed ID: 15580338
[TBL] [Abstract][Full Text] [Related]
10. Spinal cord long-term potentiation is attenuated by the NMDA-2B receptor antagonist Ro 25-6981.
Pedersen LM; Gjerstad J
Acta Physiol (Oxf); 2008 Mar; 192(3):421-7. PubMed ID: 17970830
[TBL] [Abstract][Full Text] [Related]
11. NR2A-containing NMDA receptors are required for L-LTP induction and depotentiation in CA1 region of hippocampal slices.
Zhang L; Meng K; Li YH; Han TZ
Eur J Neurosci; 2009 Jun; 29(11):2137-44. PubMed ID: 19490087
[TBL] [Abstract][Full Text] [Related]
12. Synaptic strength at the temporoammonic input to the hippocampal CA1 region in vivo is regulated by NMDA receptors, metabotropic glutamate receptors and voltage-gated calcium channels.
Aksoy-Aksel A; Manahan-Vaughan D
Neuroscience; 2015 Nov; 309():191-9. PubMed ID: 25791230
[TBL] [Abstract][Full Text] [Related]
13. Contribution of NR2A and NR2B NMDA subunits to bidirectional synaptic plasticity in the hippocampus in vivo.
Fox CJ; Russell KI; Wang YT; Christie BR
Hippocampus; 2006; 16(11):907-15. PubMed ID: 17024679
[TBL] [Abstract][Full Text] [Related]
14. Role of NMDA receptor subtypes in governing the direction of hippocampal synaptic plasticity.
Liu L; Wong TP; Pozza MF; Lingenhoehl K; Wang Y; Sheng M; Auberson YP; Wang YT
Science; 2004 May; 304(5673):1021-4. PubMed ID: 15143284
[TBL] [Abstract][Full Text] [Related]
15. Differential roles of NR2A and NR2B-containing NMDA receptors in LTP and LTD in the CA1 region of two-week old rat hippocampus.
Bartlett TE; Bannister NJ; Collett VJ; Dargan SL; Massey PV; Bortolotto ZA; Fitzjohn SM; Bashir ZI; Collingridge GL; Lodge D
Neuropharmacology; 2007 Jan; 52(1):60-70. PubMed ID: 16904707
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
[TBL] [Abstract][Full Text] [Related]
17. [Involvement of protein tyrosine kinases in β-amyloid protein-induced suppression of long-term potentiation in the rat hippocampal CA1 region in vivo].
Guo F; Li XY; Wang XH; Qi JS
Sheng Li Xue Bao; 2009 Jun; 61(3):263-71. PubMed ID: 19536439
[TBL] [Abstract][Full Text] [Related]
18. Induction- and conditioning-protocol dependent involvement of NR2B-containing NMDA receptors in synaptic potentiation and contextual fear memory in the hippocampal CA1 region of rats.
Zhang XH; Wu LJ; Gong B; Ren M; Li BM; Zhuo M
Mol Brain; 2008 Sep; 1():9. PubMed ID: 18826591
[TBL] [Abstract][Full Text] [Related]
19. Vagal afferent-dependent cholecystokinin modulation of visceral pain requires central amygdala NMDA-NR2B receptors in rats.
Wang EM; Li WT; Yan XJ; Chen X; Liu Q; Feng CC; Cao ZJ; Fang JY; Chen SL
Neurogastroenterol Motil; 2015 Sep; 27(9):1333-43. PubMed ID: 26197883
[TBL] [Abstract][Full Text] [Related]
20. Long-term potentiation in the nucleus accumbens requires both NR2A- and NR2B-containing N-methyl-D-aspartate receptors.
Schotanus SM; Chergui K
Eur J Neurosci; 2008 Apr; 27(8):1957-64. PubMed ID: 18412616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
